Why the study?
Prevention and early detection of CKD are major public health goals, prompting the need to estimate the prevalence of CKD stages 1 to 5 and its determinants in French adults.
In a large French population-based cohort, the prevalence of CKD was 6.26%, with the majority of cases driven by increased albuminuria rather than decreased eGFR, highlighting the importance of albuminuria screening.
May inform European CKD screening strategies; leaves open whether albuminuria detection improves outcomes in low-prevalence cohorts.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Blacher et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: